drug
IMNN-001
Phase 3updated 3mo agoby $IMNN Imunon, Inc.
Phase 3community read0 votes
all catalysts(0)
nothing on the calendar yet
Trials studying IMNN-001
- phase3Phase 3 Trial Evaluating the Safety & Efficacy of IMNN-001 Administered in Combination w/ Standard NACT & Adjuvant Chemotherapy in Newly Diagnosed Patients w/ Advanced EOC, Fallopian Tube or Primary Peritoneal Cancer
- phase2Phase II IMNN-001 (Also Known as GEN-1) on SLL With BEV and NACT, Newly Diagnosed Advanced Ovarian, Fallopian Tube or Primary Peritoneal Cancer
- phase2Study of IMNN-001 (Also Known as GEN-1) With NACT for Treatment of Ovarian Cancer (OVATION 2)
- phase1Study of Safety & Biological Activity of IP IMNN-001 (also Known As GEN-1) with Neoadjuvant Chemo in Ovarian Cancer
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 42m ago
Found something off?
comments(0)
5-min edit window · permanent after that